Published in Annu Rev Physiol on January 01, 1989
Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04
Review. Meiotic drive and sex determination: molecular and cytological mechanisms of sex ratio adjustment in birds. Philos Trans R Soc Lond B Biol Sci (2008) 1.40
The Ah receptor and the mechanism of dioxin toxicity. Biochem J (1991) 1.22
Association of casein kinase 2 with nuclear chromatin in relation to androgenic regulation of rat prostate. Proc Natl Acad Sci U S A (1993) 0.91
Rapid induction of the c-jun protooncogene in the avian oviduct by the antiestrogen tamoxifen. Proc Natl Acad Sci U S A (1991) 0.77
Sex hormones, autoimmune diseases, and immune responses. BMJ (1991) 0.75
Evidence of estrogen receptors in normal human osteoblast-like cells. Science (1988) 2.85
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology (1999) 2.69
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology (1999) 2.27
Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res (1996) 2.16
Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res (2000) 1.98
Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res (1995) 1.97
Nonhistone chromosomal proteins and gene regulation. Science (1974) 1.92
Skeletal effects of estrogen. Endocr Rev (1994) 1.91
Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res (1995) 1.89
Progesterone-binding components of chick oviduct. 3. Chromatin acceptor sites. J Biol Chem (1971) 1.77
Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest (1997) 1.67
Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart (2005) 1.65
Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci U S A (1991) 1.65
Partial purification of the Epstein-Barr virus nuclear antigen(s). J Biol Chem (1983) 1.44
Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res (1999) 1.44
The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology (2000) 1.43
Proteins of chromatin in template restriction. I. RNA synthesis in vitro. Biochim Biophys Acta (1971) 1.39
Mechanisms of interaction of a hormone--receptor complex with the genome of a eukaryotic target cell. Nature (1972) 1.38
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun (1998) 1.33
Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen. J Virol (1982) 1.25
Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology (1991) 1.25
Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J Cell Biochem (1998) 1.23
Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J Biol Chem (2000) 1.17
Early effects of oestradiol-17 on the chromatin and activity of the deoxyribonucleic acid-dependent ribonucleic acid polymerases (I and II) of the rat uterus. Biochem J (1972) 1.17
Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad Sci U S A (1999) 1.17
Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci U S A (1989) 1.13
Specific methods for the isolation of nuclei from chick oviduct. Methods Enzymol (1974) 1.12
TIEG-null mice display an osteopenic gender-specific phenotype. Bone (2008) 1.10
New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit Rev Eukaryot Gene Expr (1992) 1.10
Proteins of chromatin in template restriction. 3. The macromolecules in specific restriction of the chromatin DNA. Biochim Biophys Acta (1971) 1.10
Progesterone-binding components of chick oviduct. V. Exchange of progesterone-binding capacity from target to nontarget tissue chromatins. J Biol Chem (1972) 1.10
Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol (2001) 1.08
Zeolite A increases proliferation, differentiation, and transforming growth factor beta production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res (1992) 1.08
Echistatin, a potential new drug for osteoporosis. Endocrinology (1993) 1.08
Estrogen regulation of a transforming growth factor-beta inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts. Endocrinology (1998) 1.08
Deoxyribonucleoproteins and the tissue-specific restriction of the deoxyribonucleic acid in chromatin. Biochem J (1970) 1.05
Capillary electrophoresis: a powerful microanalytical technique for biologically active molecules. Biotechniques (1993) 1.05
Soluble complexes between steroid hormones and target-tissue receptors bind specifically to target-tissue chromatin. Proc Natl Acad Sci U S A (1971) 1.03
Proteins of chromatin in template restriction. II. Specificity of RNA synthesis. Biochim Biophys Acta (1971) 1.03
Tissue differences in antigenic properties of non-histone protein-DNA complexes. Nature (1971) 1.02
Comparison and characterization of nuclear isolation procedures as applied to chick oviduct. J Cell Biol (1973) 1.02
Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem (2003) 1.02
Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology (1992) 1.01
Mammalian RNA polymerases I and II: independent diurnal variations in activity. Biochem Biophys Res Commun (1972) 1.01
Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology (1993) 1.01
Structure studies on chromatin and nucleohistones. Thermal denaturation profiles recorded in the presence of urea. Biochemistry (1971) 1.00
Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines. J Endocrinol (2003) 0.97
Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma. J Bone Miner Res (1998) 0.97
TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. Biochem Biophys Res Commun (2010) 0.97
Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology (1993) 0.97
Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun (2001) 0.96
Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res (1999) 0.96
Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem (1999) 0.95
Effect of TGF-beta inducible early gene deficiency on flexor tendon healing. J Orthop Res (2006) 0.94
Chromatin of the developing chick oviduct: changes in the acidic proteins. Biochim Biophys Acta (1973) 0.93
Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology (1997) 0.93
Cytokine-specific induction of the TGF-beta inducible early gene (TIEG): regulation by specific members of the TGF-beta family. J Cell Biochem (2000) 0.92
Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res (1996) 0.92
Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest (1998) 0.92
Nuclear binding of progesterone in hen oviduct. Binding to multiple sites in vitro. Biochem J (1976) 0.92
Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells. J Cell Biochem (1992) 0.91
TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells. J Cell Biochem (1995) 0.91
Estrogen inhibition of periosteal bone formation in rat long bones: down-regulation of gene expression for bone matrix proteins. Endocrinology (1990) 0.90
The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. Bone (2007) 0.90
Role of nuclear proteins as high affinity sites ("acceptors") for progesterone in the avian oviduct. J Steroid Biochem (1977) 0.89
Nuclear binding of progesterone in chick oviduct. Multiple binding sites in vivo and transcriptional response. Biochem J (1976) 0.88
Pulmonary lymphangiomyomatosis: with particular reference to steroid-receptor assay studies and pathologic correlation. Mayo Clin Proc (1984) 0.88
Nuclear binding of progesterone in hen oviduct. Role of acidic chromatin proteins in high-affinity binding. Biochem J (1976) 0.87
Lack of a direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res (1991) 0.87
Circannual rhythms in steroid receptor concentration and nuclear binding in the chick oviduct. Endocrinology (1980) 0.87
Feedback regulation of vitamin D metabolism by 1,25-dihydroxycholecalciferol. Biochem J (1977) 0.87
Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int (1998) 0.87
Chromosomal proteins regulate steroid binding to chromatin. Nature (1976) 0.87
Progesterone binding to hen oviduct genome: specific versus nonspecific binding. Science (1976) 0.86
Evidence for interleukin-1 beta production by cultured normal human osteoblast-like cells. J Bone Miner Res (1991) 0.86
Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem (1995) 0.86
Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity. Endocrinology (1992) 0.86
Aspects of chromosomal structure. I. Circular dichroism studies. Biochemistry (1971) 0.86
Nuclear binding of estrogen-receptor complex: receptor-specific nuclear acceptor sites. Endocrinology (1982) 0.86
A nuclear binding assay to assess the biological activity of steroid receptors in isolated animal and human tissues. Endocrinology (1987) 0.86
TGFbeta-inducible early gene (TIEG) also codes for early growth response alpha (EGRalpha): evidence of multiple transcripts from alternate promoters. Genomics (1998) 0.86
Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology (1999) 0.86
Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors. J Cell Biochem (2008) 0.86
Steroid hormone regulation of nuclear proto-oncogenes. Endocr Rev (1993) 0.86
Isolation and quantitation of endogenous vitamin D and its physiologically important metabolites in human plasma by high pressure liquid chromatography. J Steroid Biochem (1977) 0.86
Changes in chromatin composition and hormone binding during chick oviduct development. Biochim Biophys Acta (1971) 0.85
Characterization of the mouse TGFbeta-inducible early gene (TIEG): conservation of exon and transcriptional regulatory sequences with evidence of additional transcripts. Mamm Genome (1998) 0.85
Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem (2001) 0.85
Effects of orbital spaceflight on human osteoblastic cell physiology and gene expression. Bone (2000) 0.84
Nuclear binding sites ("acceptors") for progesterone in avian oviduct: characterization of the highest-affinity sites. Ann N Y Acad Sci (1977) 0.84
Nuclear matrix localization and specific matrix DNA binding by receptor binding factor 1 of the avian oviduct progesterone receptor. Biochemistry (1991) 0.83
Support for chromatin acidic proteins as acceptors for progesterone in the chick oviduct. J Steroid Biochem (1979) 0.83
Rapid regulation of c-myc protooncogene expression by progesterone in the avian oviduct. Proc Natl Acad Sci U S A (1988) 0.83
Acceptor sites for the oestrogen receptor in hen oviduct chromatin. Biochem J (1983) 0.83
Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. Endocrinology (1982) 0.83
Zeolite A inhibits osteoclast-mediated bone resorption in vitro. J Cell Biochem (1995) 0.83
Effects of estrogen and progesterone on transcription, chromatin and ovalbumin gene expression in the chick oviduct. Biochim Biophys Acta (1976) 0.83
Isolation and characterization of the estrogen receptor in human skin. J Clin Endocrinol Metab (1980) 0.83
Rapid inhibition of c-myc gene expression by a glucocorticoid in the avian oviduct. Mol Endocrinol (1989) 0.82